Antifungal Potential of Moringa Olifera Against Otomycosis
NCT ID: NCT04768829
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
10 participants
INTERVENTIONAL
2021-02-18
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles
NCT06072716
Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis
NCT03130738
Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis
NCT05660382
Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)
NCT04432376
Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.
NCT04824261
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
(1) Otomycosis .
Exclusion criteria:
1. tympanic membrane perforation;
2. concurrent immune suppression,
3. and concurrent bacterial infection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo group
Nystatin ear drops formulations prepared as intervention except for the addition of Moringa prepared using biodegradable polymers in aseptic condition and tested for sensitivity
Ear Drop
plain ear drop formulation without moringa
Moringa group
Moringa ear drops prepared using biodegradable polymers in aseptic condition and tested for sensitivity
Moringa oleifera leaf 10mg/100ml
ear drops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moringa oleifera leaf 10mg/100ml
ear drops
Ear Drop
plain ear drop formulation without moringa
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ear inflammation
Exclusion Criteria
2. concurrent immune suppression,
3. concurrent bacterial infection.
20 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Deraya University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soad Ali
principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soad A Mohamad
Role: PRINCIPAL_INVESTIGATOR
Deraya University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Soad A. Mohamad
Minya, Minya Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S85Motic
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.